Showing 1851-1860 of 3871 results for "".
- iS Clinical Executives Explain Impact of New Peel Systemhttps://modernaesthetics.com/news/is-clinical-executives-explain-impact-of-new-peel-system/2475354/The next evolution of iS Clinical’s Active Peel System is the iS Clinical Extra Strength Active Peel Brightening System, which launched this week exclusively through authorized iS Clinical professionals nationwide, the company announced. The system’s professional-grade results include
- DefenAge Skincare Product Selected as NewBeauty Readers' Choice Award Winnerhttps://modernaesthetics.com/news/defenage-skincare-product-selected-as-newbeauty-readers-choice-award-winner/2473685/DefenAge Skincare’s 3D Eye Radiance Cream was named the NewBeauty 2024 Readers’ Choice Award winner. The recognition is part of NewBeauty’s second annual Readers’ Choice Awards, celebrating products that were most recognized by beauty enthusiasts. Defe
- Kenvue to Present New Data on Skincare Products at EADV Congresshttps://modernaesthetics.com/news/kenvue-to-present-new-data-on-skincare-products-at-eadv-congress/2473676/Kenvue announced the presentation of seven new data sets at the 2024 European Academy of Dermatology and Venereology (EADV) Congress this week in Amsterdam, Netherlands. The studies will feature Kenvue’s Aveeno and Neutrogena brands, “demonstrating the key to improved s
- New Product Line for Hair, Scalp Introduced by Elevai Labs Inc.https://modernaesthetics.com/news/new-product-line-for-hair-scalp-introduced-by-elevai-labs-inc/2473616/Elevai Skincare, a subsidiary of Elevai Labs Inc., announced the Elevai S-Series, a hair and scalp product line. The three-part hair and scalp care system combines the power of exosomes with advanced mitochondrial technology. The product incorporates Elevai’s proprietary pre
- AestheticWires’s Toxin Pipeline Watch: RelabotulinumtoxinA Smoothes Crow’s Feet and Frown Lines Quickly and Results Last in Phase IIIb Studieshttps://modernaesthetics.com/news/aestheticwiress-toxin-pipeline-watch-relabotulinumtoxina-smoothes-crows-feet-and-frown-lines-quickly-and-results-last-in-phase-iiib-studies/2473537/RelabotulinumtoxinA produces rapid and long-lasting effects on crow’s feet and frown kines, according to topline results from two phase IIIb studies. Galderma’s relabotulinumtoxinA is a novel liquid formulation of botulinum toxin A currently being investigated globally.
- Modern Aesthetics® Named Exclusive Media Partner for Octane’s Aesthetics Tech Forum for Second Year in a Rowhttps://modernaesthetics.com/news/modern-aesthetics-named-exclusive-media-partner-for-octanes-aesthetics-tech-forum-for-second-year-in-a-row/2473520/Modern Aesthetics® magazine is the exclusive media partner for Octane’s Aesthetics Tech Forum for the second consecutive year. This year’s Forum will take place at the Balboa Bay Resort in Newport Beach, Calif. January 25-26, 2024.
- FDA Grants 510(k) Clearance to Venus the Versa Pro Systemhttps://modernaesthetics.com/news/fda-grants-510k-clearance-to-venus-the-versa-pro-system/2473495/The U.S. Food and Drug Administration has granted marketing clearance to Venus Concept Inc.’s Venus Versa Pro System. Venus Versa is customizable and upgradable and supports 10 optional applicators which utilize Venus Concept’s (MP)2, IPL and NanoFractional RF tec
- Estée Lauder, Manchester United Partner to Boost Fans’ Skin Healthhttps://modernaesthetics.com/news/estee-lauder-manchester-united-partner-to-boost-fans-skin-health/2473451/Estée Lauder will team up with Manchester United, to reach and engage their extensive fanbase in China and the Asia Pacific region. Kicking off in Summer 2023, the partnership’s inaugural campaign will launch with players from Manchester United’s first team, inc
- LASEROPTEK Co. Ltd. Taps Dr. Neil Shah as New KOLhttps://modernaesthetics.com/news/laseroptek-co-ltd-taps-dr-neil-shah-as-new-kol/2473433/Neil Shah, MD, is now a national key opinion leader (KOL) for LASEROPTEK's PALLAS UVB laser system for inflammatory skin conditions. LASEROPTEK's PALLAS laser system is a UVB laser that is US Food and Drug Administration (FDA) -cleared to treat inflammatory skin condit
- Exosome News: Elevai Labs Scores Grant to Better Characterize Stem Cell-derived Exosomeshttps://modernaesthetics.com/news/elevai-labs-scores-grant-to-better-characterize-stem-cell-derived-exosomes/2473403/Elevai Labs is partnering with Dr. Stanislav Sokolenko’s Lab at Dalhousie University in Nova Scotia, Canada to better characterize Elevai 's stem cell-derived exosomes thanks to a non-repayable grant from the Mitacs Accelerate Grants Program (“Mitacs”).